.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Randomized studies have established the levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective medical option for heavy menstrual bleeding. Compared with oral medical therapies, LNG-IUS often provides a larger reduction in menstrual blood loss and can improve quality of life. For gynecologists, it is especially useful in women who desire contraception or wish to avoid hysterectomy. Appropriate evaluation of structural causes, anemia and malignancy risk remains necessary before insertion. Counseling should cover irregular bleeding during the first months and the expected timeline of improvement. The evidence supports LNG-IUS as a practical fertility-sparing treatment for many women with nonmalignant heavy bleeding.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Randomized studies have established the levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective medical option for heavy menstrual bleeding. Compared with oral medical therapies, LNG-IUS often provides a larger reduction in menstrual blood loss and can improve quality of life. For gynecologists, it is especially useful in women who desire contraception or wish to avoid hysterectomy. Appropriate evaluation of structural causes, anemia and malignancy risk remains necessary before insertion. Counseling should cover irregular bleeding during the first months and the expected timeline of improvement. The evidence supports LNG-IUS as a practical fertility-sparing treatment for many women with nonmalignant heavy bleeding.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
